Japan · Delayed Price · Currency is JPY SanBio Company Statistics
Total Valuation
SanBio Company has a market cap or net worth of JPY 75.79 billion. The enterprise value is 62.98 billion.
| Market Cap | 75.79B |
| Enterprise Value | 62.98B |
Important Dates
The next confirmed earnings date is Monday, September 14, 2026.
| Earnings Date | Sep 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SanBio Company has 78.06 million shares outstanding. The number of shares has increased by 12.04% in one year.
| Current Share Class | 78.06M |
| Shares Outstanding | 78.06M |
| Shares Change (YoY) | +12.04% |
| Shares Change (QoQ) | +1.66% |
| Owned by Insiders (%) | 24.88% |
| Owned by Institutions (%) | 4.83% |
| Float | 58.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 5.98 |
| P/TBV Ratio | 6.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 53.00, with a Debt / Equity ratio of 0.09.
| Current Ratio | 53.00 |
| Quick Ratio | 51.82 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.31 |
| Interest Coverage | -99.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -26.25% |
| Weighted Average Cost of Capital (WACC) | 5.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -95.35M |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -172.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.42% in the last 52 weeks. The beta is 0.28, so SanBio Company's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -58.42% |
| 50-Day Moving Average | 1,079.30 |
| 200-Day Moving Average | 1,836.33 |
| Relative Strength Index (RSI) | 44.54 |
| Average Volume (20 Days) | 764,450 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.74B |
| Pretax Income | -3.32B |
| Net Income | -3.15B |
| EBITDA | -3.73B |
| EBIT | -3.74B |
| Earnings Per Share (EPS) | -42.11 |
Balance Sheet
The company has 14.00 billion in cash and 1.18 billion in debt, with a net cash position of 12.82 billion or 164.21 per share.
| Cash & Cash Equivalents | 14.00B |
| Total Debt | 1.18B |
| Net Cash | 12.82B |
| Net Cash Per Share | 164.21 |
| Equity (Book Value) | 12.68B |
| Book Value Per Share | 162.42 |
| Working Capital | 14.05B |
Cash Flow
In the last 12 months, operating cash flow was -3.76 billion and capital expenditures -32.00 million, giving a free cash flow of -3.79 billion.
| Operating Cash Flow | -3.76B |
| Capital Expenditures | -32.00M |
| Depreciation & Amortization | 7.75M |
| Net Borrowing | 812.00M |
| Free Cash Flow | -3.79B |
| FCF Per Share | -48.58 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SanBio Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.04% |
| Shareholder Yield | -12.04% |
| Earnings Yield | -4.15% |
| FCF Yield | -5.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SanBio Company is 1,580.00, which is 65.97% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,580.00 |
| Price Target Difference | 65.97% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |